Grant: Discovery Grants Program - Individual
University of Alberta
$25,000.00
Dynamics of liver lipid droplets
FY 2020-21
Summary
Lipid droplets (LDs) are organelles present in essentially all organisms. LDs are composed of a hydrophobic core of lipids, mainly triacylglycerol (TG) and some steryl esters (SE), which is surrounded by a monolayer of amphipathic phospholipids and decorated with LD-associated proteins. LDs serve as energy (fuel) storage but also play an important role in cell signaling, viral infection and protein degradation. LD biogenesis in eukaryotes initiates from the endoplasmic reticulum (ER) where TG and SE are synthesized. However, little is known about the mechanism by which LDs accrue TG and grow in size. The liver is a central organ for energy metabolism because TG stored in LDs are either oxidized to generate energy (ATP and ketone bodies) in mitochondria or are assembled into very-low density lipoproteins (VLDL) that are then secreted into the blood. Ketone bodies and VLDL-TG serve as an important source of energy for extra-hepatic tissues. The liver contains two enzymes that are responsible TG synthesis: diacylglycerol acyltransferases 1 and 2 (DGAT1 and DGAT2). We have shown that TG synthesized by DGAT1 in hepatocytes is deposited in small LDs that are preferentially used for oxidation, while TG synthesized by DGAT2 is incorporated into large LDs that are preferentially used for VLDL assembly. Therefore, hepatic LD dynamics appear to be very complex.
We hypothesize that hepatic LDs acquire distinct set of proteins and enzymes according to the nutritional needs of the animal (during fasting or refeeding). We also hypothesize that LDs containing TG synthesized by DGAT1 have a distinct set of proteins and possibly lipid composition from those synthesized by DGAT2.
Objectives:
1) Determine protein and lipid composition of hepatic LDs during various stages of LD synthesis. Methods: Primary mouse hepatocytes will be incubated with fatty acids together with fluorescently tagged fatty acids (tracer) in the presence or absence of DGAT1 or DGAT2 inhibitors. Incubations will be stopped at various time points, LDs will be isolated by centrifugation, sorted by flow cytometry and analyzed for protein and lipid composition.
2) Characterize mouse liver LD protein and lipid composition in fasted and refed states. Methods: Mice will be either fasted overnight or fasted overnight followed by 6 hours refeeding. Livers will be harvested, lipid droplets isolated and subjected to detailed proteomic (mass spectrometry) and lipidomics (liquid chromatography-mass spectrometry) analyses.
3) Mechanism of targeting of LD-associated proteins to LDs containing TG synthesized by either DGAT1 or DGAT2 (using specific DGAT1 and DGAT2 inhibitors) will be analyzed.
Expected results: We expect to significantly advance knowledge about hepatic LD synthesis and dynamics. Gaining this knowledge is of fundamental importance because hepatic LDs play a central role in the regulation of fuel supply to other tissues.
Program
Discovery Grants Program - Individual
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2017-04734
Name nom
Lehner, Richard
Department département
Pediatrics
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2017
Award amount
25000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5109
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Intra-cellular targeting
Research subject fr
Cibles intra-cellulaires
Installment
inst:4-5
Partie
2
Nb partie
5
Application title
Dynamics of liver lipid droplets
Keyword
NSERC
Application summary
Lipid droplets (LDs) are organelles present in essentially all organisms. LDs are composed of a hydrophobic core of lipids, mainly triacylglycerol (TG) and some steryl esters (SE), which is surrounded by a monolayer of amphipathic phospholipids and decorated with LD-associated proteins. LDs serve as energy (fuel) storage but also play an important role in cell signaling, viral infection and protein degradation. LD biogenesis in eukaryotes initiates from the endoplasmic reticulum (ER) where TG and SE are synthesized. However, little is known about the mechanism by which LDs accrue TG and grow in size. The liver is a central organ for energy metabolism because TG stored in LDs are either oxidized to generate energy (ATP and ketone bodies) in mitochondria or are assembled into very-low density lipoproteins (VLDL) that are then secreted into the blood. Ketone bodies and VLDL-TG serve as an important source of energy for extra-hepatic tissues. The liver contains two enzymes that are responsible TG synthesis: diacylglycerol acyltransferases 1 and 2 (DGAT1 and DGAT2). We have shown that TG synthesized by DGAT1 in hepatocytes is deposited in small LDs that are preferentially used for oxidation, while TG synthesized by DGAT2 is incorporated into large LDs that are preferentially used for VLDL assembly. Therefore, hepatic LD dynamics appear to be very complex.
We hypothesize that hepatic LDs acquire distinct set of proteins and enzymes according to the nutritional needs of the animal (during fasting or refeeding). We also hypothesize that LDs containing TG synthesized by DGAT1 have a distinct set of proteins and possibly lipid composition from those synthesized by DGAT2.
Objectives:
1) Determine protein and lipid composition of hepatic LDs during various stages of LD synthesis. Methods: Primary mouse hepatocytes will be incubated with fatty acids together with fluorescently tagged fatty acids (tracer) in the presence or absence of DGAT1 or DGAT2 inhibitors. Incubations will be stopped at various time points, LDs will be isolated by centrifugation, sorted by flow cytometry and analyzed for protein and lipid composition.
2) Characterize mouse liver LD protein and lipid composition in fasted and refed states. Methods: Mice will be either fasted overnight or fasted overnight followed by 6 hours refeeding. Livers will be harvested, lipid droplets isolated and subjected to detailed proteomic (mass spectrometry) and lipidomics (liquid chromatography-mass spectrometry) analyses.
3) Mechanism of targeting of LD-associated proteins to LDs containing TG synthesized by either DGAT1 or DGAT2 (using specific DGAT1 and DGAT2 inhibitors) will be analyzed.
Expected results: We expect to significantly advance knowledge about hepatic LD synthesis and dynamics. Gaining this knowledge is of fundamental importance because hepatic LDs play a central role in the regulation of fuel supply to other tissues.